Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiro Takahashi

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Investigative Dermatology|March 12, 2016
Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune CellsTetsuo Toyama, Yoshihide Asano, Kaname Akamata, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding abilityKaname Akamata, Yoshihide Asano, Takashi Yamashita, et al.
The Journal of Dermatology|April 15, 2024
Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosisTakuya Takahashi, Takehiro Takahashi, Tetsuya Ikawa, et al.
Experimental Dermatology|June 17, 2025
A Potential Contribution of S100A11 to Skin Fibrosis and Pulmonary Involvement in Systemic SclerosisTakuya Takahashi, Takehiro Takahashi, Yuichiro Segawa, et al.
The Journal of Dermatology|December 26, 2025
Ritlecitinib in Alopecia Areata: A 24-Week Real-World Experience Contrasting JAK Inhibitor-Naïve and JAK Inhibitor-Experienced PatientsToshiki Okazaki, Takehiro Takahashi, Moyuka Wada-Irimada, et al.
Cancer Chemotherapy and Pharmacology|April 12, 2019
Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracilMasae Sekido, Ken-Ichi Fujita, Yutaro Kubota, et al.
The Journal of Dermatology|November 24, 2025
Coronary Artery Disease Assessment in Psoriasis Patients Well-Controlled Under Systemic Anti-Inflammatory Treatments-A Real-World Observational Study From a Single CenterToshiki Okazaki, Hitoshi Terui, Takehiro Takahashi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosisTakehiro Takahashi, Yoshihide Asano, Yohei Ichimura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic SclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Journal of Dermatological Science|January 22, 2020
Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in sclerodermaShunsuke Miura, Yoshihide Asano, Ryosuke Saigusa, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Investigative Dermatology|March 12, 2016
Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune CellsTetsuo Toyama, Yoshihide Asano, Kaname Akamata, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding abilityKaname Akamata, Yoshihide Asano, Takashi Yamashita, et al.
The Journal of Dermatology|April 15, 2024
Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosisTakuya Takahashi, Takehiro Takahashi, Tetsuya Ikawa, et al.
Experimental Dermatology|June 17, 2025
A Potential Contribution of S100A11 to Skin Fibrosis and Pulmonary Involvement in Systemic SclerosisTakuya Takahashi, Takehiro Takahashi, Yuichiro Segawa, et al.
The Journal of Dermatology|December 26, 2025
Ritlecitinib in Alopecia Areata: A 24-Week Real-World Experience Contrasting JAK Inhibitor-Naïve and JAK Inhibitor-Experienced PatientsToshiki Okazaki, Takehiro Takahashi, Moyuka Wada-Irimada, et al.
Cancer Chemotherapy and Pharmacology|April 12, 2019
Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracilMasae Sekido, Ken-Ichi Fujita, Yutaro Kubota, et al.
The Journal of Dermatology|November 24, 2025
Coronary Artery Disease Assessment in Psoriasis Patients Well-Controlled Under Systemic Anti-Inflammatory Treatments-A Real-World Observational Study From a Single CenterToshiki Okazaki, Hitoshi Terui, Takehiro Takahashi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosisTakehiro Takahashi, Yoshihide Asano, Yohei Ichimura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic SclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Journal of Dermatological Science|January 22, 2020
Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in sclerodermaShunsuke Miura, Yoshihide Asano, Ryosuke Saigusa, et al.
Pageof 14